Analyst consensus rating
IDEXX Laboratories Analyst Rating: Buy
Direct answer
IDEXX Laboratories's consensus rating is Buy.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $698.92.
Forecast evidence checked September 16, 2026.
Get free IDEXX Laboratories email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $510.73
- Average price target
- $698.92
- High price target
- $805.00
- Low price target
- $470.00
- Low target gap
- -8%
- Target upside
- +36.8%
- High target gap
- +57.6%
- Target range width
- 65.6%
- Consensus rating
- Buy
- Analysts
- 13
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for IDEXX Laboratories?
IDEXX Laboratories has a verified Buy consensus. The same dataset has an average price target of $698.92.
How far are IDEXX Laboratories's low and high targets from the recorded price?
The low target implies -8%, while the high target implies +57.6%.
How many analysts are included in IDEXX Laboratories's consensus?
The verified consensus includes 13 analysts.
How is IDEXX Laboratories's target upside or downside calculated?
The average target of $698.92 is divided by the recorded price of $510.73, then one is subtracted to produce +36.8%. This does not guarantee a future return.
When was IDEXX Laboratories's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.